Anixa Biosciences Statistics
NASDAQ: ANIXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.95-0.07 (-2.32%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Anixa Biosciences by the numbers
Anixa Biosciences has a market capitalization of $102.6 million based on 34.76M shares outstanding. With trailing EPS of $-0.32, Anixa Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.6% below its 50-day average and 1.6% below its 200-day average.
Average daily trading volume is 301.35K shares, or about $888,980 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ANIX valuation vs. peer median
| Metric | ANIX | Peer median | Difference |
|---|---|---|---|
| Market cap | $102.55M | $104.14M | -2% |
| Avg. volume | 301.35K | 237.42K | +27% |
Peer median across 8 companies: CPIX, IMUX, PLYX, KZIA, CRBP, AARD, BMEA, OKUR.
Valuation
- Market cap
- $102.55M
- EPS (TTM)
- $-0.32
- Shares outstanding
- 34.76M
Price and trading
- Previous close
- 3.02
- Open
- 3.01
- Day range
- 2.93 – 3.06
- 52-week range
- 2.32 – 5.46
- 52-week change
- -28.22%
- Beta
- —
- Volume
- 245.24K
- Average volume
- 301.35K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Sep 9, 2026
Additional statistics
- Market Cap
- 102.55M
- Forward Pe
- -9.52
- Eps
- -0.32
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.46
- Week52 Low
- 2.32
- Avg Volume
- 301.35K
- Shares Outstanding
- 34.76M
- Ma50
- 3.16
- Ma200
- 3.00
- Earnings Date
- Sep 9, 2026
- Pct From52w High
- -45.97%
- Pct From52w Low
- 27.16%